Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Switching to Iloperidone From Other Antipsychotics in Schizophrenia

ClinicalTrials.gov ID: NCT01207414

Public ClinicalTrials.gov record NCT01207414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Randomized, Multi-center, Open-Label, Iloperidone, (12-24 mg/Day), Flexible Dose Study Assessing Efficacy, Safety and Tolerability of Two Switch Approaches in Schizophrenia Patients Currently Receiving Risperidone, Olanzapine or Aripiprazole

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the clinical outcome of two switching strategies to iloperidone treatment in adult subjects with schizophrenia who require a change in their current antipsychotic treatment of risperidone, olanzapine, or aripiprazole due to suboptimal efficacy and/or safety/tolerability reasons.

Study identification

NCT ID
NCT01207414
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis
Industry
Enrollment
501 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2010 (Type not available)
Primary completion
Jan 2012 (Actual)
Completion
Jan 2012 (Actual)
Last update posted
Mar 15, 2013

2010 – 2012

United States locations

U.S. sites
59
U.S. states
20
U.S. cities
49
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226 —
Comprehensive Neuroscience Cerritos California 90703 —
ATP Clinical Research Center, Inc. Costa Mesa California 92626 —
Collaborative Neuroscience Network Garden Grove California 92845 —
Apostle Clinical Trials, Inc. Long Beach California 90813 —
Pacific Health Systems National City California 91950 —
Pacific Research Partners Oakland California 94612 —
Excell Research, Inc. Oceanside California 92056 —
University of California, Irvine Orange California 92868 —
CNRI San Diego San Diego California 92102 —
Affiliated Research Institute San Diego California 92108 —
Artemis Institute for Clinical Research San Diego California 92108 —
Neuropsychiatric Research Center of Orange County Santa Ana California 92701 —
Viking Clinical Research Temecula California 92591 —
Collaborative Neuroscience Torrance California 90502 —
The Hospital of Central Connecticut New Britain Connecticut 06052 —
Comprenhensive Neuroscience Washington D.C. District of Columbia 20016 —
Amit K. Vijapura MD & Associates Jacksonville Florida 32256 —
Scientific Clinical Research North Miami Florida 33161 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Comprehensive Neuroscience Atlanta Georgia 30328 —
Northwest Behavioral Research Center Marietta Georgia 30060 —
Carman Research Smyrna Georgia 30080 —
Institute for Behavioral Medicine Smyrna Georgia 30080 —
Alexian Brothers Center for Mental Health Arlington Heights Illinois 60005 —
Rush University Medical Center, Treatment Research Center Chicago Illinois 60612 —
University of Illinois at Chicago Chicago Illinois 60612 —
AMR - Baber Research, Inc. Naperville Illinois 60563 —
Midwest Center for Neurobehavioral Medicine Oakbrook Terrace Illinois 60181 —
Louisiana Clinical Research Shreveport Louisiana 71115 —
Neurobehavioral Medicine Group, Clinical Trials Division Bloomfield Hills Michigan 48302 —
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307 —
Precise Research Centers Flowood Mississippi 39232 —
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63301 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
CRI World Wide Clinical Research Company Willingboro New Jersey 08046 —
Albuquerque Neuroscience Albuquerque New Mexico 87109 —
Neurobehavioral Research Cedarhurst New York 11516 —
Comprehensive Neuroscience Fresh Meadows New York 11366 —
Division of Psychiatry Research - Zucker Hills Hospital Glen Oaks New York 11004 —
Finger Lakes Clinical Research Rochester New York 14618 —
Behavioral Medical Research Staten Island New York 10305 —
Richmond Behavioral Associates Staten Island New York 10312 —
North Coast Clinical Trials Beachwood Ohio 44122 —
Neurobehavioral Clinical Research Canton Ohio 44718 —
IPS Research Company Oklahoma City Oklahoma 73103 —
SP Research, PLLC Oklahoma City Oklahoma 73112 —
Belmont Center for Comprehensive Treatment Philadelphia Pennsylvania 19131 —
CRI Worldwide, LLC - Kirkbride Division Philadelphia Pennsylvania 19139 —
Carolina Clinical Trials Charleston South Carolina 29407 —
Community Clinical Research, Inc. Austin Texas 78754 —
KRK Medical Research Dallas Texas 75230 —
FutureSearch Trials Dallas Texas 75231 —
InSite Clinical Research DeSoto Texas 75115 —
Bayou City Research Limited Houston Texas 77007 —
Claghorn-Lesem Research Clinic, Inc Houston Texas 77008 —
Mary Ann Knesevich, MD, PA Irving Texas 75062 —
InSite Clinical Research Plano Texas 75074 —
Frontier Institute Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01207414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2013 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01207414 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →